Cultural Challenges of BlueBird Bio Expansion into Germany
BlueBird Bio is a biotechnology multinational corporation (MNC), with headquarters in Cambridge, Massachusetts, specializing in gene therapy solutions for autoimmune diseases and cancer. The company was recently approved, in Germany, for their new drug Zynteglo for the treatment of betta thalassemia...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
St. John's University, Tobin College of Business
2020-12-01
|
| Series: | Journal of Global Awareness |
| Subjects: | |
| Online Access: | https://doi.org/10.24073/jga/1/02/06 |